Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down‐regulation of the T cell costimulatory molecule CD40 ligand: an open …
PP Sfikakis, JN Boletis, S Lionaki… - … : Official Journal of …, 2005 - Wiley Online Library
Objective Autoreactive B cells play a key role in tissue injury in systemic autoimmune
disease, and therefore a treatment resulting in B cell depletion could have benefit. This open …
disease, and therefore a treatment resulting in B cell depletion could have benefit. This open …
[HTML][HTML] Deletion of CD137 ligand exacerbates renal and cutaneous but alleviates cerebral manifestations in lupus
A Mak, B Dharmadhikari, NY Kow… - Frontiers in …, 2019 - frontiersin.org
The CD137—CD137 ligand (CD137L) costimulatory system is a critical immune checkpoint
with pathophysiological implications in autoimmunity. In this study, we investigated the role …
with pathophysiological implications in autoimmunity. In this study, we investigated the role …
Suppression of autoimmunity by CD5+ IL-10-producing B cells in lupus-prone mice
Systemic lupus erythematosus is a complex autoimmune disorder characterized by the
production of pathogenic anti-nuclear antibodies. Previous work from our laboratory has …
production of pathogenic anti-nuclear antibodies. Previous work from our laboratory has …
Effective treatment of experimental lupus nephritis by combined administration of anti‐CD11a and anti‐CD54 antibodies
CJ Kootstra, DM Van Der Giezen… - Clinical & …, 1997 - Wiley Online Library
Mice with chronic graft‐versus‐host disease (GVHD), induced by injection of DBA/2
lymphocytes in (C57BL10* DBA/2) F1 hybrids, develop a syndrome resembling systemic …
lymphocytes in (C57BL10* DBA/2) F1 hybrids, develop a syndrome resembling systemic …
T helper cells driving pathogenic anti-DNA autoantibody production in lupus: nucleosomal epitopes and CD40 ligand signals
SK Datta, A Kaliyaperumal, C Mohan… - Lupus, 1997 - journals.sagepub.com
Multiple mechanisms contribute to the pathogenesis of spontaneous SLE. However, despite
the presence of polyclonal T and B cell hyperactivity, autoimmunity in lupus is not global, it is …
the presence of polyclonal T and B cell hyperactivity, autoimmunity in lupus is not global, it is …
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a …
L Schiffer, J Sinha, X Wang, W Huang… - The Journal of …, 2003 - journals.aai.org
NZB/WF 1 mice with established nephritis were treated with a single dose of
cyclophosphamide with or without a 2-wk course of murine CTLA4Ig, either alone or in …
cyclophosphamide with or without a 2-wk course of murine CTLA4Ig, either alone or in …
Distinct mechanisms of action of anti‐CD154 in early versus late treatment of murine lupus nephritis
SA Quezada, M Eckert, OA Adeyi… - … : Official Journal of …, 2003 - Wiley Online Library
Objective Treatment with anti‐CD154 antibody is known to ameliorate murine lupus
nephritis when given early in the disease. The aims of this study were to identify the …
nephritis when given early in the disease. The aims of this study were to identify the …
Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity
R Watanabe, N Ishiura, H Nakashima… - The Journal of …, 2010 - journals.aai.org
B cells play critical roles in the pathogenesis of lupus. To examine the influence of B cells on
disease pathogenesis in a murine lupus model, New Zealand Black and New Zealand White …
disease pathogenesis in a murine lupus model, New Zealand Black and New Zealand White …
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis
L Schiffer, R Bethunaickan, M Ramanujam… - The Journal of …, 2008 - journals.aai.org
Costimulatory blockade with CTLA4Ig and anti-CD40L along with a single dose of
cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/WF …
cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/WF …
Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fcγ receptor II (CD32)
S Werwitzke, D Trick, P Sondermann… - Annals of the …, 2008 - ard.bmj.com
Objectives: Systemic lupus erythematosus (SLE) is a classical autoimmune disorder
characterised by the production of IgG autoantibodies against double-stranded DNA …
characterised by the production of IgG autoantibodies against double-stranded DNA …